12/16
10:17 am
radx
Radiopharm Theranostics (NASDAQ:RADX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, up previously from $13.00.
Medium
Report
Radiopharm Theranostics (NASDAQ:RADX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, up previously from $13.00.
12/16
10:17 am
radx
Radiopharm Theranostics (NASDAQ:RADX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, up previously from $13.00.
Medium
Report
Radiopharm Theranostics (NASDAQ:RADX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, up previously from $13.00.